Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin
- PMID: 715066
- DOI: 10.1016/0161-4630(78)90047-2
Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin
Abstract
Experimental allergic encephalomyelitis in Lewis rats was suppressed by treatment with essential fatty acids (EFA) given perorally. This treatment effect could be abolished by administration of a drug (Indomethacin) known to inhibit biosynthesis of certain prostaglandins from EFA. This observation suggests that the suppressive effect of EFA on cell-mediated immune reactions is brought about by EFA-derived prostaglandins.
Similar articles
-
The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.Clin Exp Immunol. 1979 Jun;36(3):449-55. Clin Exp Immunol. 1979. PMID: 487646 Free PMC article.
-
The effect of prostaglandin precursors in in vivo models of cell-mediated immunity.Prog Lipid Res. 1981;20:649-54. doi: 10.1016/0163-7827(81)90120-x. Prog Lipid Res. 1981. PMID: 6979050 No abstract available.
-
Cerebral prostaglandin synthesis during the dietary and pathological stresses of essential fatty acid deficiency and experimental allergic encephalomyelitis.Lipids. 1978 Jun;13(6):408-14. doi: 10.1007/BF02533710. Lipids. 1978. PMID: 97486
-
Polyunsaturated fatty acids in the low-birth-weight infant.Semin Perinatol. 1979 Oct;3(4):341-61. Semin Perinatol. 1979. PMID: 395645 Review.
-
Essential fatty acids and immune response.FASEB J. 1989 Jul;3(9):2052-61. doi: 10.1096/fasebj.3.9.2501132. FASEB J. 1989. PMID: 2501132 Review.
Cited by
-
Polyunsaturated fatty acids and colchicine in multiple sclerosis.Br Med J. 1979 Jan 20;1(6157):199-200. doi: 10.1136/bmj.1.6157.199-d. Br Med J. 1979. PMID: 421025 Free PMC article. No abstract available.
-
Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).Inflamm Res. 2011 Oct;60(10):919-28. doi: 10.1007/s00011-011-0352-3. Epub 2011 Jun 12. Inflamm Res. 2011. PMID: 21667309
-
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.Clin Exp Immunol. 2000 Dec;122(3):445-52. doi: 10.1046/j.1365-2249.2000.01399.x. Clin Exp Immunol. 2000. PMID: 11122253 Free PMC article.
-
Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment.Clin Exp Immunol. 1980 Jun;40(3):523-31. Clin Exp Immunol. 1980. PMID: 7418264 Free PMC article.
-
Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy.Brain. 2017 Feb;140(2):370-386. doi: 10.1093/brain/aww295. Epub 2016 Dec 21. Brain. 2017. PMID: 28007986 Free PMC article.